Latest news
Loading news…
Prilenia
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Herzliya, Tel Aviv, Israel Founded 2018 11-50 employees For Profit
Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
26
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 63
Company Info
- Founded
- 2018
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 39
- HQ
- Herzliya, Tel Aviv, Israel
- Region
- Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.5
- Trend (30d)
- 2.4
- Trend (90d)
- 5.8
- Last leadership hire
- Apr 28, 2026
Key People at Prilenia
CEO
Chief Financial Officer
Head Of Finance
Chief Business Officer
26
professional contacts at Prilenia
Contact execs at Prilenia →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Prilenia
Loading news…
FAQs about Prilenia
People who checked this page also checked these
Browse the full Acquirezy directory.